IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: BioTime Symbol: BTX Price: Last trade $3.01 Description: Re-offer $2.70-$2.75 Trade Date: 2/10 Shares: 5.7 million Underwriter(s)Raymond James & Associates Rating=Subscription[…]
Secondaries announced 8.9.2016
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Acadia Pharmaceuticals, Inc. Symbol: ACAD Price: Last trade $35.23 Trade Date: 8/10 Shares: 5.7 million Underwriter(s) J.P. Morgan, Goldman Sachs, BofA[…]
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish